Previous Page  16 / 22 Next Page
Information
Show Menu
Previous Page 16 / 22 Next Page
Page Background

N: 66 pacientes

RR %: 33%

DCR: 75%

mSLP: 8 meses:

- QT: 8 meses

- QT- beva: 9 meses

- QT- anti EGFR: 10 meses

mSG: 16 m

González-Flores et al. WCGIC 2017. Poster 317